Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
2019-09-23 Sale | 2019-09-24 6:23 pm | MyoKardia Inc | MYOK | Lee June EVP, Chief Development Officer | 13,051 | $59.51 | $776,724 | 119,770 (Direct) | View |
2019-09-19 Sale | 2019-09-20 5:31 pm | MyoKardia Inc | MYOK | Lee June EVP, Chief Development Officer | 5,435 | $57.08 | $310,254 | 132,821 (Direct) | View |
2019-08-09 Sale | 2019-08-12 8:40 pm | MyoKardia Inc | MYOK | Lee June EVP, Chief Development Officer | 4,565 | $57 | $260,219 | 138,256 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
2023-06-09 Option Award | 2023-06-12 8:17 pm | 2024-06-09 2033-06-08 | Tenaya Therapeutics Inc. | TNYA | Lee June Director | 29,532 | $0 | 29,532 (Direct) | View |
2023-05-01 Option Award | 2023-05-02 6:43 pm | N/A 2033-05-01 | Eledon Pharmaceuticals Inc. | ELDN | Lee June Director | 150,437 | $0 | 150,437 (Direct) | View |
2023-02-24 Disposition | 2023-02-24 6:37 pm | N/A 2032-01-10 | CinCor Pharma Inc. | CINC | Lee June Director | 47,954 | $0 | 0 (Direct) | View |
2023-02-01 Option Award | 2023-02-02 6:05 pm | N/A 2033-02-01 | Eledon Pharmaceuticals Inc. | ELDN | Lee June Director | 20,000 | $0 | 20,000 (Direct) | View |
2022-06-10 Option Award | 2022-06-13 8:56 pm | 2023-06-10 2032-06-09 | Tenaya Therapeutics Inc. | TNYA | Lee June Director | 39,727 | $0 | 39,727 (Direct) | View |
2022-02-01 Option Award | 2022-02-02 5:32 pm | N/A 2032-02-01 | Eledon Pharmaceuticals Inc. | ELDN | Lee June Director | 20,000 | $0 | 20,000 (Direct) | View |
2022-01-06 Option Award | 2022-01-10 4:15 pm | N/A 2032-01-10 | CinCor Pharma Inc. | CINC | Lee June Director | 47,954 | $0 | 47,954 (Direct) | View |
2021-11-19 Option Award | 2021-11-22 7:41 pm | 2021-12-19 2031-11-29 | Tenaya Therapeutics Inc. | TNYA | Lee June Director | 18,937 | $0 | 18,937 (Direct) | View |
Ownership | 2020-12-14 4:05 pm | N/A 2030-12-08 | Novus Therapeutics Inc. | NVUS | Lee June Director | 0 | $0 | 40,000 (Direct) | View |
2019-09-23 Exercise | 2019-09-24 6:23 pm | N/A 2027-01-31 | MyoKardia Inc | MYOK | Lee June EVP, Chief Development Officer | 12,625 | $0 | 119,770 (Direct) | View |
2019-09-23 Exercise | 2019-09-24 6:23 pm | N/A N/A | MyoKardia Inc | MYOK | Lee June EVP, Chief Development Officer | 12,625 | $11.95 | 119,770 (Direct) | View |
2019-09-19 Exercise | 2019-09-20 5:31 pm | N/A 2027-01-31 | MyoKardia Inc | MYOK | Lee June EVP, Chief Development Officer | 5,435 | $0 | 132,821 (Direct) | View |
2019-09-19 Exercise | 2019-09-20 5:31 pm | N/A N/A | MyoKardia Inc | MYOK | Lee June EVP, Chief Development Officer | 5,435 | $11.95 | 132,821 (Direct) | View |
2019-08-09 Exercise | 2019-08-12 8:40 pm | N/A 2027-01-31 | MyoKardia Inc | MYOK | Lee June EVP, Chief Development Officer | 4,565 | $0 | 138,256 (Direct) | View |
2019-08-09 Exercise | 2019-08-12 8:40 pm | N/A N/A | MyoKardia Inc | MYOK | Lee June EVP, Chief Development Officer | 4,565 | $11.95 | 138,256 (Direct) | View |
2019-04-30 Option Award | 2019-06-03 5:48 pm | N/A N/A | MyoKardia Inc | MYOK | Lee June EVP, Chief Development Officer | 401 | $40.78 | 4,579 (Direct) | View |